Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joan L, Kramer"'
Autor:
Angela N. Giaquinto, Hyuna Sung, Kimberly D. Miller, Joan L. Kramer, Lisa A. Newman, Adair Minihan, Ahmedin Jemal, Rebecca L. Siegel
Publikováno v:
CA: A Cancer Journal for Clinicians. 72:524-541
This article is the American Cancer Society's update on female breast cancer statistics in the United States, including population-based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in mo
Autor:
K. Robin Yabroff, Julia H. Rowland, Angela B. Mariotto, Ahmedin Jemal, Rebecca L. Siegel, Leticia Nogueira, Catherine M. Alfano, Joan L. Kramer, Kimberly D. Miller
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:363-385
The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individual
Publikováno v:
CA: A Cancer Journal for Clinicians. 67:261-272
There are limited published data on the burden of rare cancers in the United States. By using data from the North American Association of Central Cancer Registries and the Surveillance, Epidemiology, and End Results program, the authors provide infor
Autor:
Angela B. Mariotto, Julia H. Rowland, Rick Alteri, Kimberly D. Miller, Kevin Stein, Ahmedin Jemal, Chun Chieh Lin, Rebecca L. Siegel, Joan L. Kramer
Publikováno v:
CA: A Cancer Journal for Clinicians. 66:271-289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society an
Autor:
Stacey A. Fedewa, Ahmedin Jemal, Ann Goding Sauer, Carol DeSantis, Robert A. Smith, Joan L. Kramer
Publikováno v:
CA: A Cancer Journal for Clinicians. 66:31-42
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 231,840 new cases of invasive breast cancer and
Autor:
Elizabeth Ward, Ahmedin Jemal, Betsy A. Kohler, Joan L. Kramer, Otis W. Brawley, Chun Chieh Lin, Ted Gansler, Carol DeSantis
Publikováno v:
CA: A Cancer Journal for Clinicians. 65:481-495
An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively co
Autor:
Chloe S. Lalonde, Christine C. Davis, Jane L. Meisel, Zhengjia Chen, Meagan Spencer Barbee, Subir Goyal, Jordyn Paige Higgins, Joan L. Kramer, Kandra Horne, Kristina F. Byers
Publikováno v:
Journal of Clinical Oncology. 38:e13085-e13085
e13085 Background: The specifics of the salvage regimen gemcitabine/carboplatin (G/C) in metastatic breast cancer (MBC) are not well-characterized and are limited to the clinical trial setting, which often excludes heavily pretreated patients with hi
Autor:
Joan L. Kramer
Publikováno v:
CA: A Cancer Journal for Clinicians. 65:109-122
Answer questions and earn CME/CNE Marijuana has been used for centuries, and interest in its medicinal properties has been increasing in recent years. Investigations into these medicinal properties has led to the development of cannabinoid pharmaceut
Autor:
Chun Chieh Lin, Rick Alteri, Anthony S. Robbins, Joan L. Kramer, Ahmedin Jemal, Angela B. Mariotto, Carol DeSantis, Rebecca L. Siegel, Kevin Stein
Publikováno v:
CA: A Cancer Journal for Clinicians. 64:252-271
The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment. In order for the public health community to better serve these survivors, the American Cancer Societ
Publikováno v:
British Journal of Haematology. 117:727-734
Iron is required for monocyte/macrophage differentiation of HL-60 leukaemia cells. Differentiation requires induction of the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1), and cell cycle arrest at the G1/S checkpoint. With iron depletion, p21 ind